ArticleFrontiers in oncology2026

Development and validation of a multimodality radiomics-based nomogram for predicting HER2 expression status in invasive breast cancer.

Xianwei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.